Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/34815
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPaton, A.-
dc.contributor.authorMorona, R.-
dc.contributor.authorPaton, J.-
dc.date.issued2006-
dc.identifier.citationDiscovery medicine, 2006; 6(31):35-39-
dc.identifier.issn1539-6509-
dc.identifier.issn1944-7930-
dc.identifier.urihttp://hdl.handle.net/2440/34815-
dc.description.abstractNearly all antibiotics aim at killing the bacteria, which eventually develop antibiotic resistance under ‘survival pressure’. The pathology exerted by many pathologic bacteria is through secreting toxins. Probiotics, either harmless live bacteria or dead ones, can be molecularly engineered to express receptors for the toxins and absorb and eliminate them from binding to their natural receptors, thus reducing or eliminating the pathological impact of bacterial infection.-
dc.description.statementofresponsibilityAdrienne W. Paton, Renato Morona, and James C. Paton-
dc.language.isoen-
dc.publisherSolariz, Inc.-
dc.source.urihttp://www.discoverymedicine.com/ViewAbstract.php?rec=10409214446231373311193-
dc.subjectAnimals-
dc.subjectHumans-
dc.subjectBacterial Infections-
dc.subjectGastrointestinal Diseases-
dc.subjectBacterial Toxins-
dc.subjectModels, Biological-
dc.subjectProbiotics-
dc.titleTreatment and Prevention of Enteric Infections With Toxin-binding Probiotics-
dc.typeJournal article-
pubs.publication-statusPublished-
dc.identifier.orcidMorona, R. [0000-0001-7009-7440]-
dc.identifier.orcidPaton, J. [0000-0001-9807-5278]-
Appears in Collections:Aurora harvest
Molecular and Biomedical Science publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.